title: The editor's roundtable: revisiting the role of beta blockers in hypertension.
authors.affiliation: Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas, Texas, USA. wc.roberts@baylorhealth.edu
authors.forename: William C
authors.initials: WC
authors.lastname: Roberts
authors.forename: Henry R
authors.initials: HR
authors.lastname: Black
authors.forename: George L
authors.initials: GL
authors.lastname: Bakris
authors.forename: R Preston
authors.initials: RP
authors.lastname: Mason
authors.forename: Thomas D
authors.initials: TD
authors.lastname: Giles
authors.forename: Destry J
authors.initials: DJ
authors.lastname: Sulkes
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001578:Benzopyrans / Q000627:therapeutic use; D001786:Blood Glucose / Q000032:analysis; D001794:Blood Pressure / Q000187:drug effects; D001919:Bradycardia / Q000139:chemically induced; D001921:Brain / Q000187:drug effects; D001986:Bronchial Spasm / Q000139:chemically induced; D004983:Ethanolamines / Q000627:therapeutic use; D006327:Heart Block / Q000139:chemically induced; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008055:Lipids / Q000097:blood; D000068577:Nebivolol; D012735:Sexual Dysfunction, Physiological / Q000139:chemically induced
chemical_list: D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D001578:Benzopyrans; D001786:Blood Glucose; D004983:Ethanolamines; D008055:Lipids; D000068577:Nebivolol